25.74
전일 마감가:
$26.22
열려 있는:
$26.22
하루 거래량:
1.97M
Relative Volume:
1.82
시가총액:
$2.26B
수익:
$23.38M
순이익/손실:
$-155.22M
주가수익비율:
-11.75
EPS:
-2.19
순현금흐름:
$-134.36M
1주 성능:
+4.59%
1개월 성능:
+7.03%
6개월 성능:
+41.35%
1년 성능:
-27.04%
Ideaya Biosciences Inc Stock (IDYA) Company Profile
명칭
Ideaya Biosciences Inc
전화
650-443-6209
주소
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA
IDYA을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
IDYA
Ideaya Biosciences Inc
|
25.74 | 2.30B | 23.38M | -155.22M | -134.36M | -2.19 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-09-18 | 개시 | Guggenheim | Buy |
2025-09-04 | 개시 | Barclays | Overweight |
2025-09-04 | 개시 | Citizens JMP | Mkt Outperform |
2025-07-22 | 개시 | TD Cowen | Buy |
2025-07-10 | 재개 | Goldman | Neutral |
2025-06-26 | 개시 | Wells Fargo | Overweight |
2024-11-18 | 개시 | Stephens | Overweight |
2024-11-05 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
2024-10-24 | 개시 | UBS | Buy |
2024-10-15 | 개시 | Cantor Fitzgerald | Overweight |
2024-07-08 | 개시 | Mizuho | Outperform |
2024-03-08 | 개시 | BTIG Research | Buy |
2023-08-08 | 개시 | SVB Securities | Outperform |
2023-05-24 | 개시 | Goldman | Buy |
2023-04-24 | 업그레이드 | Stifel | Hold → Buy |
2023-03-23 | 개시 | Berenberg | Buy |
2023-02-28 | 개시 | RBC Capital Mkts | Outperform |
2022-12-28 | 개시 | CapitalOne | Overweight |
2022-10-27 | 개시 | Citigroup | Buy |
2022-08-15 | 다운그레이드 | Stifel | Buy → Hold |
2022-07-18 | 재개 | Oppenheimer | Outperform |
2022-03-10 | 업그레이드 | Stifel | Hold → Buy |
2021-09-23 | 개시 | Stifel | Hold |
2021-06-04 | 재개 | Robert W. Baird | Outperform |
2021-03-11 | 개시 | Guggenheim | Buy |
2020-10-07 | 개시 | Wedbush | Outperform |
2020-09-01 | 개시 | Northland Capital | Outperform |
2020-07-13 | 업그레이드 | JP Morgan | Neutral → Overweight |
2020-06-17 | 재확인 | H.C. Wainwright | Buy |
2020-04-06 | 개시 | H.C. Wainwright | Buy |
2020-03-13 | 개시 | ROTH Capital | Buy |
2019-10-17 | 개시 | Oppenheimer | Outperform |
2019-09-10 | 개시 | Robert W. Baird | Outperform |
2019-06-17 | 개시 | Citigroup | Buy |
2019-06-17 | 개시 | JP Morgan | Neutral |
2019-06-17 | 개시 | Jefferies | Buy |
모두보기
Ideaya Biosciences Inc 주식(IDYA)의 최신 뉴스
Is IDEAYA Biosciences Inc stock a top performer YTD2025 Volume Leaders & Fast Exit and Entry Strategy Plans - khodrobank.com
Dip Buying: What drives IDEAYA Biosciences Incs stock priceWeekly Trend Report & Smart Investment Allocation Tips - khodrobank.com
Guidance Update: Is IDEAYA Biosciences Inc benefiting from innovation trends2025 Geopolitical Influence & High Win Rate Trade Tips - khodrobank.com
Will IDEAYA Biosciences Inc benefit from geopolitical trendsIndex Update & Real-Time Market Trend Scan - khodrobank.com
Rhumbline Advisers Purchases 10,876 Shares of IDEAYA Biosciences, Inc. $IDYA - MarketBeat
Update Recap: Is IDEAYA Biosciences Inc. benefiting from innovation trendsEarnings Growth Summary & Verified Technical Trade Signals - khodrobank.com
Take Profit: Whats the beta of IDEAYA Biosciences Inc stockJuly 2025 Closing Moves & Free Technical Confirmation Trade Alerts - khodrobank.com
Activity Recap: Is IDEAYA Biosciences Inc stock a good dividend stock2025 Technical Overview & AI Powered Trade Plan Recommendations - khodrobank.com
IDEAYA Biosciences (NASDAQ:IDYA) Coverage Initiated by Analysts at Guggenheim - MarketBeat
Buyback Watch: Will IDEAYA Biosciences Inc. outperform tech stocksWeekly Gains Summary & Weekly Watchlist for Hot Stocks - khodrobank.com
Setup Watch: Will IDEAYA Biosciences Inc benefit from geopolitical trendsShare Buyback & Risk Managed Investment Signals - khodrobank.com
IDEAYA Biosciences (NASDAQ:IDYA) Now Covered by Guggenheim - Defense World
Guggenheim Initiates Coverage of IDEAYA Biosciences (IDYA) with Buy Recommendation - Nasdaq
Market Pulse: Can IDEAYA Biosciences Inc. benefit from deglobalizationQuarterly Investment Review & Free Daily Entry Point Trade Alerts - khodrobank.com
Aug Macro: Can Skechers USA Inc stock outperform in a bear market2025 Buyback Activity & Low Drawdown Investment Ideas - khodrobank.com
Guggenheim Initiates Coverage on IDEAYA Biosciences (IDYA) with a Buy Rating | IDYA Stock News - GuruFocus
Growth Report: Is IDEAYA Biosciences Inc. stock a good dividend stockWeekly Market Summary & Weekly Top Performers Watchlists - khodrobank.com
Aug Patterns: Is IDEAYA Biosciences Inc. benefiting from innovation trendsJuly 2025 Drop Watch & Risk Managed Investment Signals - khodrobank.com
IDEAYA Biosciences, Inc. $IDYA Shares Sold by Woodline Partners LP - MarketBeat
IDEAYA Biosciences’ SWOT analysis: promising data boosts stock outlook - Investing.com India
Guggenheim Initiates IDEAYA Biosciences(IDYA.US) With Buy Rating, Announces Target Price $50 - 富途牛牛
Pullback Watch: Will IDEAYA Biosciences Inc. benefit from geopolitical trendsEarnings Risk Report & Low Risk Growth Stock Ideas - khodrobank.com
IDEAYA Biosciences’ SWOT analysis: promising data boosts stock outlook By Investing.com - Investing.com UK
Leerink Partnrs Has Bearish Outlook for IDYA FY2026 Earnings - MarketBeat
Published on: 2025-09-17 01:19:00 - khodrobank.com
IDEAYA Biosciences Stock Price, Quotes and Forecasts | NASDAQ:IDYA - Benzinga
Revenue Check: Is IDEAYA Biosciences Inc subject to activist investor interestJuly 2025 Catalysts & Expert-Curated Trade Recommendations - khodrobank.com
Published on: 2025-09-16 20:28:28 - khodrobank.com
Bond Watch: Is IDEAYA Biosciences Inc likely to announce a buybackWeekly Gains Report & Risk Managed Investment Strategies - khodrobank.com
IPO Launch: Can IDEAYA Biosciences Inc reach all time highs this yearJuly 2025 Summary & Reliable Intraday Trade Alerts - khodrobank.com
Should you hold or exit IDEAYA Biosciences Inc. now2025 Year in Review & Weekly Watchlist for Consistent Profits - newser.com
Can IDEAYA Biosciences Inc reach all time highs this yearWeekly Gains Report & Safe Capital Growth Stock Tips - khodrobank.com
Trend Review: How cyclical is Ameriprise Financial Inc.’s revenue streamMarket Performance Recap & High Accuracy Trade Alerts - خودرو بانک
Aug Sectors: Is IDEAYA Biosciences Inc a good stock for dollar cost averaging2025 Market Overview & Verified Technical Trade Signals - khodrobank.com
Sentiment Watch: Will IDEAYA Biosciences Inc. outperform small cap indexes2025 Short Interest & Safe Capital Growth Tips - khodrobank.com
Signal Recap: Is IDEAYA Biosciences Inc. likely to announce a buybackWeekly Trading Summary & Expert Approved Trade Ideas - khodrobank.com
Is IDEAYA Biosciences Inc.’s ROIC above industry averageJuly 2025 Review & Risk Managed Trade Strategies - khodrobank.com
Published on: 2025-09-15 13:23:10 - khodrobank.com
What’s IDEAYA Biosciences Inc.’s historical returnQuarterly Profit Report & Accurate Buy Signal Alerts - khodrobank.com
Research Analysts’ Recent Ratings Changes for IDEAYA Biosciences (IDYA) - Defense World
Using Bollinger Bands to evaluate IDEAYA Biosciences Inc.Forecast Cut & Precise Buy Zone Identification - newser.com
Mizuho Boosts IDEAYA Biosciences (NASDAQ:IDYA) Price Target to $44.00 - MarketBeat
Mizuho Forecasts Strong Price Appreciation for IDEAYA Biosciences (NASDAQ:IDYA) Stock - Defense World
IDEAYA Biosciences (NASDAQ:IDYA) Receives "Overweight" Rating from Cantor Fitzgerald - MarketBeat
Ideaya Biosciences gets coverage initiation at Barclays and Citizens - MSN
Could IDEAYA Biosciences' (IDYA) Expanding Pipeline Redefine Its Long-Term Value Proposition? - Yahoo
IDEAYA Biosciences, Inc. $IDYA Shares Sold by Trexquant Investment LP - MarketBeat
IDEAYA Biosciences (NASDAQ:IDYA) Shares Down 6.4%Should You Sell? - MarketBeat
American Century Companies Inc. Makes New Investment in IDEAYA Biosciences, Inc. $IDYA - MarketBeat
Mizuho Raises Price Target on IDEAYA Biosciences (IDYA) to $44 | IDYA Stock News - GuruFocus
LifeSci Capital Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Maintains Target Price $58 - 富途牛牛
Ideaya Biosciences Inc (IDYA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):